In a pilot study, Zimmermann-Ivol et al. (28) investigated the sensitivity and specificity of NSE, S100B, and H-FABP in patients with acute stroke, acute myocardial infarction, and a group of control patients. This evidence concerns the gene ENO2 and myocardial infarction.